STOCK TITAN

LifeStance Appoints Dr. Teresa DeLuca to Board of Directors

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
management
Rhea-AI Summary
LifeStance Health appoints Dr. Teresa DeLuca, an experienced healthcare executive and psychiatrist, to its board of directors. Dr. DeLuca brings over 20 years of leadership experience from companies like Magellan Health and Humana, enhancing LifeStance's clinical management and healthcare operations.
Positive
  • None.
Negative
  • None.

SCOTTSDALE, Ariz., March 12, 2024 /PRNewswire/ -- LifeStance Health, one of the nation's largest providers of virtual and in-person outpatient mental healthcare, today announced that Dr. Teresa DeLuca has joined the company's board of directors. Dr. DeLuca is a psychiatrist and accomplished physician executive with over 20 years of leadership experience, having held senior executive leadership roles at Magellan Health, Humana and Walgreens, and brings extensive healthcare operations and clinical management expertise to LifeStance's board of directors.

"Dr. DeLuca's background as a tenured healthcare executive and practicing psychiatrist make her a tremendous addition to our board of directors," said Ken Burdick, Chairman and CEO, LifeStance. "As an organization focused on clinical quality and delivering exceptional patient outcomes, I'm confident that her skills and expertise will be a strong complement to our current board as we continue to expand access to much needed mental healthcare across the country."

"As the leader in comprehensive, high-quality mental healthcare, LifeStance is truly making a difference in the lives of its patients while also meaningfully addressing the growing mental health crisis," said Dr. DeLuca. "I'm thrilled to join the organization as it continues to advance its mission, and I look forward to working alongside Ken and the board of directors at LifeStance to help even more patients receive the personalized care they need."

Dr. DeLuca most recently served as Managing Director of Columbia University's NY Life Science Venture, which focused on bringing life sciences research and promising early-stage technologies to market. Previously, she was the Chief Medical Officer at Magellan Health where she spearheaded first-to-market products and technologies, including integrating behavioral health data with pharmacy claims and clinical management. Prior to Magellan Health, Dr. DeLuca served as SVP, Health Solutions at Humana, where she oversaw sales, operations and clinical management. She currently serves on the Board of Directors for Surgery Partners and Rejuveron. Dr. DeLuca received an MBA from Drexel University's LeBow College of Business and her medical degree from Thomas Jefferson University.

ABOUT LIFESTANCE HEALTH
Founded in 2017, LifeStance (NASDAQ: LFST) is reimagining mental health. We are one of the nation's largest providers of virtual and in-person outpatient mental healthcare for children, adolescents and adults experiencing a variety of mental health conditions. Our mission is to help people lead healthier, more fulfilling lives by improving access to trusted, affordable and personalized mental healthcare. LifeStance employs approximately 6,600 psychiatrists, advanced practice nurses, psychologists and therapists and operates across 33 states and more than 550 centers. To learn more, please visit www.LifeStance.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/lifestance-appoints-dr-teresa-deluca-to-board-of-directors-302086204.html

SOURCE LifeStance Health

FAQ

Who recently joined LifeStance Health's board of directors?

Dr. Teresa DeLuca, an accomplished psychiatrist and healthcare executive, recently joined LifeStance Health's board of directors.

What is Dr. DeLuca's background in healthcare?

Dr. DeLuca has over 20 years of leadership experience and has held senior executive roles at Magellan Health, Humana, and Walgreens.

What is Dr. DeLuca's current role at Columbia University?

Dr. DeLuca most recently served as Managing Director of Columbia University's NY Life Science Venture.

Where did Dr. DeLuca receive her MBA from?

Dr. DeLuca received her MBA from Drexel University's LeBow College of Business.

LifeStance Health Group, Inc.

NASDAQ:LFST

LFST Rankings

LFST Latest News

LFST Stock Data

2.57B
382.62M
11.11%
91.06%
3.62%
Medical Care Facilities
Services-health Services
Link
United States of America
SCOTTSDALE